BRIEF-Biocartis and Amgen collaborate on rapid RAS biomarker testing
Feb 3 (Reuters) - Biocartis Group NV :
* Biocartis and Amgen collaborate to offer rapid RAS biomarker testing to selected hospitals and clinics in Brazil, Canada, Colombia, Mexico, Saudi Arabia, Spain and Turkey
* Biocartis and Amgen have entered into a collaboration to evaluate idylla RAS testing as tool for rapid decentralized testing Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
© Thomson Reuters 2017 All rights reserved.